Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400088611Phase 4Not yet recruiting
Phase 4, randomised trial of oliceridine in postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Proportion of subjects reaching SAME. Planned start Aug 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400088611.